Working… Menu
Trial record 2 of 37 for:    hannan

Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02353819
Recruitment Status : Active, not recruiting
First Posted : February 3, 2015
Last Update Posted : May 13, 2021
Information provided by (Responsible Party):
Raquibul Hannan, University of Texas Southwestern Medical Center

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : December 2022